跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 8,894 条关于
“TauRx Pharmaceuticals”
全部
8,894
临床试验
526
药物
1,725
机构
2,045
资讯
4,598
去年
TauRx Secures $119 Million Investment as Novel Tau-Targeting Alzheimer's Drug Advances Toward Regulatory Filing
去年
TauRx's LMTX Shows Promising Results for Alzheimer's Treatment with Potential to Become First Oral Disease-Modifying Therapy
去年
Hydromethylthionine Mesylate: Oral Alzheimer's Drug Under NHS Consideration
去年
HanAll, Daewoong, and NurrOn Announce Positive Phase 1 Results for Parkinson's Disease Therapy HL192 (ATH-399A)
去年
Bora Pharmaceuticals Acquires Pyros Pharmaceuticals, Expanding Rare Disease Portfolio
9个月前
Johnson & Johnson's Posdinemab Fails Phase 2b Trial, Dealing Blow to Tau-Targeting Alzheimer's Therapies
去年
MIRA Pharmaceuticals to Acquire SKNY Pharmaceuticals, Expanding into $200 Billion Weight Loss and Smoking Cessation Markets
去年
ARIAD Pharmaceuticals Accelerates Ponatinib to Market
去年
OnKure Therapeutics Advances Mutant-Specific PI3Kα Inhibitor OKI-219 Following Merger
去年
Quoin Pharmaceuticals Expands Netherton Syndrome Clinical Trials to the UK
第 1 页,共 460 页
上一页
下一页